Sterols as novel immunomodulatory agents and their use as vaccine adjuvants
US-2026053912-A1 · Feb 26, 2026 · US
This page is not indexed by search engines while we improve data quality.
Bachelder Eric patents
Bachelder Eric is listed as an inventor on 15 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Bachelder Eric |
| Total patents | 15 |
| First publication | May 5, 2016 |
| Latest publication | Feb 26, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Sterols as novel immunomodulatory agents and their use as vaccine adjuvants
US-12478671-B2 · Nov 25, 2025 · US
Composite bioactive compositions and applications thereof
US-2025295762-A1 · Sep 25, 2025 · US
Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using same
US-2022211680-A1 · Jul 7, 2022 · US
Methods and compositions for inducing an immune response
US-11052149-B2 · Jul 6, 2021 · US
Compositions for targeting macrophages and other CD206 high expressing cells and methods of treating and diagnosis
US-10806803-B2 · Oct 20, 2020 · US
Sterols as novel immunomodulatory agents and their use as vaccine adjuvants
US-2020197514-A1 · Jun 25, 2020 · US
Methods and compositions for inducing an immune response
US-2019275144-A1 · Sep 12, 2019 · US
Antileishmanial compositions and methods of use
US-10174072-B2 · Jan 8, 2019 · US
Compositions and methods for inhibiting leishmania
US-2018185334-A1 · Jul 5, 2018 · US
Recent patents
Latest publications not already listed above.
Compositions and methods for inhibiting leishmania
US-9901569-B2 · Feb 27, 2018 · US
Antileishmanial compositions and methods of use
US-2017305959-A1 · Oct 26, 2017 · US
Compositions for targeting macrophages and other cd206 high expressing cells and methods of treating and diagnosis
US-2017209584-A1 · Jul 27, 2017 · US
Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using same
US-2017202969-A1 · Jul 20, 2017 · US
Compositions and methods for inhibiting leishmania
US-2016120844-A1 · May 5, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ohio State Innovation Foundation | 12 |
| Univ North Carolina Chapel Hill | 3 |
| Cardinal Health 414 Llc | 2 |
| Schlesinger Larry | 2 |
| Cope Fred | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.